OxRML/AgentSLR huggingface dataset:
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Human delay - Start of treatment to End of treatment
Value: 4 Days
Value type: Median
Uncertainty: 3 - 6 (IQR)
Combined uncertainty: 3 - 6 (IQR)
Timing of estimate: Unspecified
Delay type: Start of treatment to end of treatment
Other delay: Start of treatment to End of treatment (Start of treatment to End of treatment)
Population group: Persons under investigation (Hospital based)
Population sex: Both
Sample size: 354
Country: Liberia, Sierra Leone
Study period: 15 Sep 2014 - 31 Dec 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Zaire Ebola virus (EBOV)
Outbreak: Unspecified
Parameter: Risk factors
Timing of estimate: Post outbreak
Risk factor: Other
Risk factor outcome: Other
Risk factor significant: Significant
Risk factor adjusted: Adjusted
Other risk factor outcome: Reporting death of household member/relative
Population group: Persons under investigation (Household based)
Population sex: Both
Population age range: 15 - 59
Sample size: 11928
Country: Liberia
Study period: 2019 - 2020
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: DRC, 2018-2020
Parameter: Risk factors
Timing of estimate: Unspecified
Risk factor: Other
Risk factor outcome: Infection
Risk factor significant: Not significant
Risk factor adjusted: Unspecified
Population group: Persons under investigation (Hospital based)
Population sex: Both
Sample size: 579
Country: DRC
Location: Ituri, North Kivu, South Kivu
Study period: Jul 2018 - May 2020
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: DRC, 2018-2020
Parameter: Risk factors
Timing of estimate: Unspecified
Risk factor: Age
Risk factor outcome: Death
Risk factor significant: Significant
Risk factor adjusted: Not adjusted
Population group: Persons under investigation (Hospital based)
Population sex: Both
Sample size: 579
Country: DRC
Location: Ituri, North Kivu, South Kivu
Study period: Jul 2018 - May 2020
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: DRC, 2018-2020
Parameter: Severity - case fatality rate (CFR)
Value: 61.8 Percentage (%)
Value type: Other
Range: 3.1 - 94
CFR/IFR numerator: 61
CFR/IFR denominator: 579
CFR/IFR method: Unspecified
Timing of estimate: Unspecified
Disaggregated by: Age, Occupation
Population group: Persons under investigation (Hospital based)
Population sex: Both
Sample size: 579
Country: DRC
Location: Ituri, North Kivu, South Kivu
Study period: Jul 2018 - May 2020
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Zaire Ebola virus (EBOV)
Outbreak: West Africa 2013-2016
Parameter: Seroprevalence - IgG
Value:  Percentage (%)
Value type: Other
Range: 1.5 - 6.1
CFR/IFR denominator: 600
CFR/IFR method: Naive
Timing of estimate: Unspecified
Disaggregated by: Other
Population group: Other (Other)
Population sex: Unspecified
Sample size: 600
Country: Mali
Location: Bamba, Banzana, Soromba
Study period: 2015
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Seroprevalence - IgG
Value: 8.3 Percentage (%)
Value type: Other
CFR/IFR numerator: 113
CFR/IFR denominator: 1366
CFR/IFR method: Unspecified
Timing of estimate: Unspecified
Population group: Other (Community based)
Population sex: Both
Sample size: 1366
Country: DRC
Location: Boende, Kabondo-Dianda, Yambuku, North and South Kikwit
Study period: Sep 2015 - Aug 2017
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Risk factor: Sex
Risk factor outcome: Serology
Risk factor significant: Significant
Risk factor adjusted: Not adjusted
Population group: Other (Community based)
Population sex: Both
Sample size: 1366
Country: DRC
Location: Boende, Kabondo-Dianda, Yambuku, North and South Kikwit
Study period: Sep 2015 - Aug 2017
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Risk factor: Age;Close contact;Occupation;Other
Risk factor outcome: Serology
Risk factor occupation: Healthcare
Risk factor significant: Not significant
Risk factor adjusted: Not adjusted
Population group: Other (Community based)
Population sex: Both
Sample size: 1366
Country: DRC
Location: Boende, Kabondo-Dianda, Yambuku, North and South Kikwit
Study period: Sep 2015 - Aug 2017
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Risk factor: Contact with animal;Other
Risk factor outcome: Serology
Risk factor significant: Significant
Risk factor adjusted: Adjusted
Population group: Other (Community based)
Population sex: Both
Sample size: 1366
Country: DRC
Location: Boende, Kabondo-Dianda, Yambuku, North and South Kikwit
Study period: Sep 2015 - Aug 2017
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Risk factor: Contact with animal;Other
Risk factor outcome: Serology
Risk factor significant: Not significant
Risk factor adjusted: Adjusted
Population group: Other (Community based)
Population sex: Both
Sample size: 1366
Country: DRC
Location: Boende, Kabondo-Dianda, Yambuku, North and South Kikwit
Study period: Sep 2015 - Aug 2017
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Human delay - Symptom Onset/Fever to Admission to Care/Hospitalisation
Value: 4 Days
Value type: Mean
Distribution: Weibull
Distribution parameter 1: 4 (Mean)
Distribution parameter 2: 2.3 (Mean sd)
Timing of estimate: Post outbreak
Delay type: Symptom onset to admission to care
Other delay: Symptom Onset/Fever to Admission to Care/Hospitalisation (Symptom Onset/Fever to Admission to Care/Hospitalisation)
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 20
Country: Nigeria
Study period: 17 Jul 2014 - 20 Oct 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Human delay - serial interval
Value: 15.3 Days
Value type: Mean
Distribution: Gamma
Distribution parameter 1: 15.3 (Mean)
Distribution parameter 2: 2.3 (Mean sd)
Timing of estimate: Post outbreak
Delay type: Serial interval
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 20
Country: Nigeria
Study period: 17 Jul 2014 - 20 Oct 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Reproduction number (Basic R0)
Value: 10 No units
Value type: Mean
Uncertainty: 3 - 18.5 (95% CrI)
Combined uncertainty: 3 - 18.5 (95% CrI)
Estimation method: Branching process
Timing of estimate: Post outbreak
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 20
Country: Nigeria
Study period: 17 Jul 2014 - 20 Oct 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Reproduction number (Basic R0)
Value: 3.2 No units
Value type: Mean
Uncertainty: 0.8 - 16.4 (95% CrI)
Combined uncertainty: 0.8 - 16.4 (95% CrI)
Estimation method: Branching process
Timing of estimate: Post outbreak
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 20
Country: Nigeria
Study period: 17 Jul 2014 - 20 Oct 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Reproduction number (Effective, Re)
Estimation method: Branching process
Timing of estimate: Post outbreak
Disaggregated by: Time
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 20
Country: Nigeria
Study period: 17 Jul 2014 - 20 Oct 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Human delay - incubation period
Value: 9.3 Days
Value type: Mean
Uncertainty (single): 1.9 (Standard Deviation)
Combined uncertainty: 1.9 (Standard Deviation)
Timing of estimate: Post outbreak
Delay type: Incubation period
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 20
Country: Nigeria
Study period: 17 Jul 2014 - 20 Oct 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Reproduction number (Basic R0)
Value: 1.3 No units
Value type: Unspecified
Uncertainty: 1.26 - 2.53 (Range)
Combined uncertainty: 1.26 - 2.53 (Range)
Estimation method: Other
Country: Sierra Leone
Study period: 12 May 2014 - 13 Nov 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Severity - case fatality rate (CFR)
Value:  Percentage (%)
Value type: Unspecified
Range: 19 - 46
Disaggregated by: Other, Time
Country: Sierra Leone
Study period: 12 May 2014 - 13 Nov 2015
Pathogen: Ebola virus
Ebola species: Bundibugyo
Ebola variant: Bundibugyo virus (BDBV)
Outbreak: DRC, 2012
Parameter: Human delay - infectious period  (inverse parameter)
Value: 0.19 Days
Value type: Mean
Uncertainty: 0.13 - 0.28 (95% CrI)
Uncertainty (single): 0.04 (Standard Deviation)
Combined uncertainty: 0.13 - 0.28 (95% CrI)
Timing of estimate: Unspecified
Delay type: Infectious period
Population group: Persons under investigation (Community based)
Population sex: Unspecified
Sample size: 37
Country: DRC
Location: Isiro
Study period: 2012
Pathogen: Ebola virus
Ebola species: Bundibugyo
Ebola variant: Bundibugyo virus (BDBV)
Outbreak: DRC, 2012
Parameter: Reproduction number (Basic R0)
Value: 1.37 No units
Value type: Mean
Uncertainty: 0.85 - 2.02 (95% CrI)
Uncertainty (single): 0.3 (Standard Deviation)
Combined uncertainty: 0.85 - 2.02 (95% CrI)
Estimation method: Branching process
Timing of estimate: Unspecified
Population group: Persons under investigation (Community based)
Population sex: Unspecified
Sample size: 37
Country: DRC
Location: Isiro
Study period: 2012
Pathogen: Ebola virus
Ebola species: Bundibugyo
Ebola variant: Bundibugyo virus (BDBV)
Outbreak: DRC, 2012
Parameter: Human delay - infectious period  (inverse parameter)
Value: 0.18 Days
Value type: Mean
Uncertainty: 0.13 - 0.24 (95% CrI)
Uncertainty (single): 0.03 (Standard Deviation)
Combined uncertainty: 0.13 - 0.24 (95% CrI)
Timing of estimate: Unspecified
Delay type: Infectious period
Population group: Persons under investigation (Community based)
Population sex: Unspecified
Sample size: 37
Country: DRC
Location: Isiro
Study period: 2012
Pathogen: Ebola virus
Ebola species: Bundibugyo
Ebola variant: Bundibugyo virus (BDBV)
Outbreak: DRC, 2012
Parameter: Reproduction number (Basic R0)
Value: 1.11 No units
Value type: Mean
Uncertainty: 1.06 - 1.17 (95% CrI)
Uncertainty (single): 0.03 (Standard Deviation)
Combined uncertainty: 1.06 - 1.17 (95% CrI)
Estimation method: Other
Timing of estimate: Unspecified
Population group: Persons under investigation (Community based)
Population sex: Unspecified
Sample size: 37
Country: DRC
Location: Isiro
Study period: 2012
Pathogen: Ebola virus
Ebola species: Bundibugyo
Ebola variant: Bundibugyo virus (BDBV)
Outbreak: DRC, 2012
Parameter: Human delay - infectious period  (inverse parameter)
Value: 0.22 Days
Value type: Mean
Uncertainty: 0.12 - 0.36 (95% CrI)
Uncertainty (single): 0.06 (Standard Deviation)
Combined uncertainty: 0.12 - 0.36 (95% CrI)
Timing of estimate: Unspecified
Delay type: Infectious period
Population group: Persons under investigation (Hospital based)
Population sex: Unspecified
Sample size: 11
Country: DRC
Location: Isiro
Study period: 2012
Pathogen: Ebola virus
Ebola species: Bundibugyo
Ebola variant: Bundibugyo virus (BDBV)
Outbreak: DRC, 2012
Parameter: Reproduction number (Basic R0)
Value: 0.86 No units
Value type: Mean
Uncertainty: 0.37 - 1.6 (95% CrI)
Uncertainty (single): 0.32 (Standard Deviation)
Combined uncertainty: 0.37 - 1.6 (95% CrI)
Estimation method: Branching process
Timing of estimate: Unspecified
Population group: Persons under investigation (Hospital based)
Population sex: Unspecified
Sample size: 11
Country: DRC
Location: Isiro
Study period: 2012
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: DRC, 2018-2020
Parameter: Growth rate (r)
Value: 0.12 Per week
Value type: Median
Uncertainty: 0.11 - 0.14 (95% CI)
Combined uncertainty: 0.11 - 0.14 (95% CI)
Timing of estimate: Unspecified
Population group: General population (Population based)
Population sex: Unspecified
Country: DRC
Location: North Khivu and Ituri
Study period: 6 Sep 2018 - 11 Mar 2019
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Human delay - Symptom Onset/Fever to Reporting
Value:  Days
Value type: Mean
Range: 2.4 - 7.3
Timing of estimate: Mid outbreak
Disaggregated by: Other, Time
Delay type: Symptom onset to reporting
Other delay: Symptom Onset/Fever to Reporting (Symptom Onset/Fever to Reporting)
Population group: General population (Population based)
Population sex: Both
Country: Sierra Leone
Location: Koinadugu
Study period: 11 Oct 2014 - Unspecified
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Severity - case fatality rate (CFR)
Value: 51.4 Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 38
CFR/IFR denominator: 74
CFR/IFR method: Unspecified
Timing of estimate: Mid outbreak
Population group: General population (Population based)
Population sex: Both
Population age range: 0.6 - 80
Sample size: 74
Country: Sierra Leone
Location: Koinadugu
Study period: 11 Oct 2014 - 9 Dec 2014
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Reproduction number (Effective, Re)
Value: 1.3 No units
Value type: Unspecified
Estimation method: Empirical (contact tracing)
Timing of estimate: Mid outbreak
Disaggregated by: Other
Population group: General population (Population based)
Population sex: Both
Population age range: 0.6 - 80
Sample size: 74
Country: Sierra Leone
Location: Koinadugu
Study period: 11 Oct 2014 - Unspecified
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Reproduction number (Effective, Re)
Value: 4 No units
Value type: Unspecified
Estimation method: Empirical (contact tracing)
Timing of estimate: Mid outbreak
Disaggregated by: Disease generation
Population group: General population (Population based)
Population sex: Both
Population age range: 0.6 - 80
Sample size: 74
Country: Sierra Leone
Location: Koinadugu
Study period: 11 Oct 2014 - Unspecified
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Zaire Ebola virus (EBOV)
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Timing of estimate: Unspecified
Disaggregated by: Other
Risk factor: Age;Other
Risk factor outcome: Serology
Risk factor significant: Significant
Risk factor adjusted: Adjusted
Population group: Other (Hospital based)
Population sex: Both
Population age range: 1 - 
Sample size: 687
Country: Guinea
Study period: 23 Mar 2015 - 30 Nov 2018
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Zaire Ebola virus (EBOV)
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Timing of estimate: Unspecified
Disaggregated by: Other
Risk factor: Age;Other;Sex
Risk factor outcome: Serology
Risk factor significant: Not significant
Risk factor adjusted: Adjusted
Population group: Other (Hospital based)
Population sex: Both
Population age range: 1 - 
Sample size: 687
Country: Guinea
Study period: 23 Mar 2015 - 30 Nov 2018
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Zaire Ebola virus (EBOV)
Outbreak: West Africa 2013-2016
Parameter: Seroprevalence - IgG
Value:  Percentage (%)
Value type: Unspecified
Range: 59.41 - 99.8
CFR/IFR method: Adjusted
Disaggregated by: Other, Time
Population group:  (Hospital based)
Country: Guinea
Study period: 23 Mar 2015 - 11 Jul 2016
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Seroprevalence - IgG
Value: 22.5 Percentage (%)
Value type: Unspecified
Range: 0 - 37
CFR/IFR numerator: 131
CFR/IFR denominator: 582
CFR/IFR method: Adjusted
Timing of estimate: Post outbreak
Disaggregated by: Age, Level of exposure, Other, Sex
Population group: Healthcare workers (Hospital based)
Population sex: Both
Sample size: 582
Country: DRC
Location: Boende
Study period: Nov 2015
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Timing of estimate: Post outbreak
Risk factor: Occupation;Other;Sex
Risk factor outcome: Serology
Risk factor occupation: Other
Risk factor significant: Significant
Risk factor adjusted: Not adjusted
Population group: Healthcare workers (Hospital based)
Population sex: Both
Sample size: 582
Country: DRC
Location: Boende
Study period: Nov 2015
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Timing of estimate: Post outbreak
Risk factor: Age;Close contact;Occupation;Other
Risk factor outcome: Serology
Risk factor occupation: Other
Risk factor significant: Not significant
Risk factor adjusted: Not adjusted
Population group: Healthcare workers (Hospital based)
Population sex: Both
Sample size: 582
Country: DRC
Location: Boende
Study period: Nov 2015
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Timing of estimate: Post outbreak
Risk factor: Other
Risk factor outcome: Serology
Risk factor significant: Significant
Risk factor adjusted: Adjusted
Population group: Healthcare workers (Hospital based)
Population sex: Both
Sample size: 582
Country: DRC
Location: Boende
Study period: Nov 2015
Pathogen: Ebola virus
Ebola species: Unspecified
Ebola variant: Unspecified
Outbreak: Unspecified
Parameter: Risk factors
Timing of estimate: Post outbreak
Risk factor: Close contact;Contact with animal;Funeral;Other
Risk factor outcome: Serology
Risk factor significant: Not significant
Risk factor adjusted: Adjusted
Population group: Healthcare workers (Hospital based)
Population sex: Both
Sample size: 582
Country: DRC
Location: Boende
Study period: Nov 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Mutations - evolutionary rate
Value:  Substitutions/site/year
Timing of estimate: Post outbreak
Genome site: Whole genome
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 600
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Mutations - evolutionary rate
Value:  Substitutions/site/year
Timing of estimate: Post outbreak
Genome site: Glycoprotein
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 600
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Mutations - evolutionary rate
Value: 0.82 Substitutions/site/year
Value type: Unspecified
Timing of estimate: Post outbreak
Genome site: Whole genome
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 600
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Mutations - evolutionary rate
Value: 0.73 Substitutions/site/year
Value type: Unspecified
Timing of estimate: Post outbreak
Genome site: Glycoprotein
Population group: Unspecified (Unspecified)
Population sex: Unspecified
Sample size: 600
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2015
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Risk factor: Age;Other;Sex
Risk factor outcome: Infection
Risk factor significant: Not significant
Risk factor adjusted: Not adjusted
Population group: Other (Household based)
Population sex: Both
Sample size: 838
Country: Sierra Leone
Location: Freetown
Study period: 15 Dec 2014 - 30 Apr 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significant: Significant
Risk factor adjusted: Not adjusted
Population group: Other (Household based)
Population sex: Both
Sample size: 838
Country: Sierra Leone
Location: Freetown
Study period: 15 Dec 2014 - 30 Apr 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significant: Significant
Risk factor adjusted: Adjusted
Population group: Other (Household based)
Population sex: Both
Sample size: 838
Country: Sierra Leone
Location: Freetown
Study period: 15 Dec 2014 - 30 Apr 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Timing of estimate: Mid outbreak
Risk factor: Age;Other
Risk factor outcome: Other
Risk factor significant: Significant
Risk factor adjusted: Not adjusted
Other risk factor outcome: RNA persistence
Other delay: Symptom Onset/Fever to Death (Symptom Onset/Fever to Death)
Population group: Persons under investigation (Population based)
Population sex: Male
Population age range: 19 - 69
Sample size: 131
Country: Liberia
Study period: Jun 2015 - Jun 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Risk factors
Timing of estimate: Mid outbreak
Risk factor: Other
Risk factor outcome: Other
Risk factor significant: Significant
Risk factor adjusted: Adjusted
Other risk factor outcome: RNA persistence
Population group: Persons under investigation (Population based)
Population sex: Male
Population age range: 19 - 69
Sample size: 131
Country: Liberia
Study period: Jun 2015 - Jun 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Severity - case fatality rate (CFR)
Value: 82.8 Percentage (%)
Value type: Mean
Uncertainty: 45.6 - 85.6 (95% CI)
Combined uncertainty: 45.6 - 85.6 (95% CI)
CFR/IFR denominator: 33338
CFR/IFR method: Adjusted
Timing of estimate: Mid outbreak
Disaggregated by: Age, Other, Region, Symptoms
Population group: General population (Population based)
Population sex: Both
Sample size: 33338
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Severity - case fatality rate (CFR)
Value: 71.9 Percentage (%)
Value type: Mean
Uncertainty: 56.1 - 79.8 (95% CI)
Combined uncertainty: 56.1 - 79.8 (95% CI)
CFR/IFR denominator: 33338
CFR/IFR method: Naive
Timing of estimate: Mid outbreak
Disaggregated by: Age, Other, Region, Symptoms
Population group: General population (Population based)
Population sex: Both
Sample size: 18644
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2016
Pathogen: Ebola virus
Ebola species: Zaire
Ebola variant: Unspecified
Outbreak: West Africa 2013-2016
Parameter: Severity - case fatality rate (CFR)
Value: 75.1 Percentage (%)
Value type: Mean
Uncertainty: 73.5 - 76.6 (95% CI)
Combined uncertainty: 73.5 - 76.6 (95% CI)
CFR/IFR denominator: 18644
CFR/IFR method: Naive
Timing of estimate: Mid outbreak
Disaggregated by: Age, Other, Region, Symptoms
Population group: General population (Population based)
Population sex: Both
Sample size: 33338
Country: Guinea, Liberia, Sierra Leone
Study period: 2013 - 2016